Federated Hermes, Inc. Coherus Bio Sciences, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 582 shares of CHRS stock, worth $855. This represents 0.0% of its overall portfolio holdings.

Number of Shares

582

Holding current value

$855

% of portfolio

0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.99 - $1.8 $576 - $1,047	582 New	582 $0
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $10,740 - $20,777	1,498 Added 54.97%	4,223 $41,000
Q2 2022 Aug 15, 2022	SELL	$5.86 - $13.23 $12,974 - $29,291	-2,214 Reduced 44.83%	2,725 $20,000
Q1 2022 May 13, 2022	BUY	$10.92 - $16.41 $7,731 - $11,618	708 Added 16.73%	4,939 $64,000
Q4 2021 Feb 14, 2022	SELL	$15.81 - $18.99 $109,089 - $131,030	-6,900 Reduced 61.99%	4,231 $68,000
Q3 2021 Nov 15, 2021	BUY	$12.68 - $17.79 $141,141 - $198,020	11,131 New	11,131 $179,000
Q2 2021 Aug 16, 2021	SELL	$12.95 - $15.41 $2,084 - $2,481	-161 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$14.42 - $21.39 $719,630 - $1.07 Million	-49,905 Reduced 99.68%	161 $2,000
Q4 2020 Feb 12, 2021	BUY	$16.56 - $18.94 $7,037 - $8,049	425 Added 0.86%	50,066 $870,000
Q3 2020 Nov 12, 2020	BUY	$17.41 - $19.89 $864,249 - $987,359	49,641 New	49,641 $910,000
Q4 2019 Feb 14, 2020	SELL	$16.33 - $21.37 $5.39 Million - $7.05 Million	-329,979 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$16.3 - $23.37 $3.7 Million - $5.31 Million	-227,259 Reduced 40.78%	329,979 $6.69 Million
Q2 2019 Aug 14, 2019	BUY	$13.1 - $22.1 $7.3 Million - $12.3 Million	557,238 New	557,238 $12.3 Million
Q1 2019 May 10, 2019	SELL	$8.38 - $15.5 $11,296 - $20,894	-1,348 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$8.65 - $16.28 $1.17 Million - $2.19 Million	-134,723 Reduced 99.01%	1,348 $12,000
Q3 2018 Nov 13, 2018	BUY	$14.45 - $20.25 $1.19 Million - $1.67 Million	82,334 Added 153.22%	136,071 $2.25 Million
Q2 2018 Aug 10, 2018	BUY	$10.25 - $17.45 $535,316 - $911,343	52,226 Added 3456.39%	53,737 $752,000
Q1 2018 May 09, 2018	BUY	$9.1 - $13.7 $728 - $1,096	80 Added 5.59%	1,511 $17,000
Q4 2017 Feb 14, 2018	SELL	$8.35 - $14.4 $317 - $547	-38 Reduced 2.59%	1,431 $0
Q3 2017 Nov 13, 2017	BUY	$11.1 - $14.5 $16,305 - $21,300	1,469	1,469 $20,000

Others Institutions Holding CHRS

# of Institutions

134

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $114M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Coherus Bio Sciences, Inc. Transaction History